JB Chemicals & Pharmaceuticals Limited has informed regarding Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Chemicals & Pharmaceuticals has informed the stock exchange that the NCLT Ahmedabad Bench has issued a Corrigendum Order dated March 24, 2026, in connection with the proposed amalgamation of JB Chemicals (Transferor Company) with Torrent Pharmaceuticals (Transferee Company). This is a continuation of an earlier intimation from March 24, 2026 regarding the NCLT order on the Scheme of Amalgamation. The corrigendum is a minor procedural correction to the original order and has been uploaded on the NCLT website on March 25, 2026. No new substantive changes to the deal have been indicated in this filing.
This is a procedural update confirming the NCLT's approval process for the JB Chemicals–Torrent Pharma merger is on track. Shareholders of JB Chemicals can expect to receive shares of Torrent Pharmaceuticals in exchange as per the swap ratio once the scheme becomes effective, making them shareholders of a larger combined pharmaceutical entity.